ZimVie (ZIMV) News Today → A letter is coming from the 'Bureau of the Fiscal Service'. (From Stansberry Research) (Ad) Free ZIMV Stock Alerts $17.02 +0.04 (+0.24%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 8:47 PM | uk.investing.comNeedham upgrades ZimVie shares target to Buy on implant market stabilityMay 18 at 8:51 AM | marketbeat.comZimVie Inc. (NASDAQ:ZIMV) Shares Acquired by First Eagle Investment Management LLCFirst Eagle Investment Management LLC increased its position in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 73.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 294,673 shares of the company's stock after buyingMay 18 at 2:58 AM | americanbankingnews.comNeedham & Company LLC Upgrades ZimVie (NASDAQ:ZIMV) to "Buy"May 16 at 5:32 PM | msn.comNeedham Upgrades ZimVie (ZIMV)May 16 at 4:05 PM | globenewswire.comZimVie to Participate in Upcoming Investor ConferencesMay 16 at 8:41 AM | marketbeat.comZimVie (NASDAQ:ZIMV) Raised to Buy at Needham & Company LLCNeedham & Company LLC raised ZimVie from a "hold" rating to a "buy" rating and set a $20.00 target price on the stock in a report on Thursday.May 12, 2024 | finance.yahoo.comZimVie Inc. (NASDAQ:ZIMV) Q1 2024 Earnings Call TranscriptMay 12, 2024 | americanbankingnews.comZimVie Inc. (NASDAQ:ZIMV) Short Interest Up 29.1% in AprilMay 12, 2024 | americanbankingnews.comZimVie (NASDAQ:ZIMV) Earns "Hold" Rating from Needham & Company LLCMay 11, 2024 | marketbeat.comRussell Investments Group Ltd. Purchases 105,256 Shares of ZimVie Inc. (NASDAQ:ZIMV)Russell Investments Group Ltd. grew its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 60.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 279,413 shares of the company's stock after purchasing an additioMay 10, 2024 | finance.yahoo.comZimVie Inc. (ZIMV) Reports Mixed Q1 2024 Financial Results, Misses Earnings PredictionsMay 9, 2024 | marketbeat.comZimVie (NASDAQ:ZIMV) Issues Quarterly Earnings ResultsZimVie (NASDAQ:ZIMV - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.08 EPS for the quarter. ZimVie had a negative net margin of 51.33% and a positive return on equity of 2.44%. The business had revenue of $118.20 million for the quarter. During the same quarter last year, the company posted $0.25 earnings per share.May 9, 2024 | finance.yahoo.comQ1 2024 ZimVie Inc Earnings CallMay 9, 2024 | marketbeat.comZimVie (NASDAQ:ZIMV) Given Hold Rating at Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of ZimVie in a research note on Thursday.May 9, 2024 | finance.yahoo.comZimVie Inc (ZIMV) (Q1 2024) Earnings Call Transcript Highlights: Navigating Market Challenges ...May 8, 2024 | investorplace.comZIMV Stock Earnings: ZimVie Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | marketbeat.comZimVie (NASDAQ:ZIMV) Updates FY 2024 Earnings GuidanceZimVie (NASDAQ:ZIMV) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.550-0.700 for the period, compared to the consensus estimate of 0.100. The company also issued revenue guidance of $450.0 millionillion-$460.0 millionillion, compared to the consensus estimate of $454.1 millionillion.May 8, 2024 | finance.yahoo.comZimVie Reports First Quarter 2024 Financial ResultsMay 7, 2024 | markets.businessinsider.comHere's what to expect from ZimVie's earnings reportMay 1, 2024 | marketbeat.comZimVie (ZIMV) Set to Announce Earnings on WednesdayZimVie (NASDAQ:ZIMV) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=588879)April 30, 2024 | finance.yahoo.comDental Bone Graft Substitutes Market Worth $1.8 billion | MarketsandMarkets™April 24, 2024 | globenewswire.comZimVie to Report First Quarter Financial Results on May 8, 2024April 1, 2024 | marketbeat.comZimVie (NASDAQ:ZIMV) Shares Gap Up to $16.49ZimVie (NASDAQ:ZIMV) Shares Gap Up to $16.49April 1, 2024 | bizjournals.comPublic company sells spine business to H.I.G. Capital for $375 millionApril 1, 2024 | finance.yahoo.comH.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge MedicalApril 1, 2024 | marketwatch.comZimVie Shares Rise 9% After Closing of Spine Business Sale for $375MApril 1, 2024 | globenewswire.comZimVie Announces Closing of Sale of Spine BusinessMarch 27, 2024 | globenewswire.comZimVie to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceMarch 15, 2024 | finance.yahoo.comMultiple Reasons for the Surge of ZimVie (ZIMV) in Q4March 15, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Reduces Holdings in ZimVie Inc. (NASDAQ:ZIMV)Jacobs Levy Equity Management Inc. cut its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 11.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 468,029 shares of the company's stock after selling 62,451 shares during the quaMarch 9, 2024 | marketbeat.comNatixis Advisors L.P. Takes $813,000 Position in ZimVie Inc. (NASDAQ:ZIMV)Natixis Advisors L.P. acquired a new stake in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 86,439 shares of the company's stock, valuedMarch 5, 2024 | marketbeat.comZimVie (NASDAQ:ZIMV) PT Raised to $16.00 at BarclaysBarclays boosted their target price on shares of ZimVie from $13.00 to $16.00 and gave the company an "underweight" rating in a research report on Tuesday.March 4, 2024 | marketbeat.comKent Lake Capital LLC Sells 77,571 Shares of ZimVie Inc. (NASDAQ:ZIMV)Kent Lake Capital LLC trimmed its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 5.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,300,000 shares of the company's stock after selling 77,571 shares during the period. ZimVie aMarch 3, 2024 | finance.yahoo.comOne ZimVie Inc. (NASDAQ:ZIMV) Analyst Just Cut Their EPS ForecastsMarch 1, 2024 | finanznachrichten.deZimVie Inc.: ZimVie Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 1, 2024 | seekingalpha.comZimVie Inc. (ZIMV) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finance.yahoo.comZimVie Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 29, 2024 | finance.yahoo.comQ4 2023 ZimVie Inc Earnings CallFebruary 29, 2024 | finance.yahoo.comZimVie Inc. (NASDAQ:ZIMV) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | benzinga.comRecap: ZimVie Q4 EarningsFebruary 28, 2024 | fool.comZimVie (ZIMV) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | finance.yahoo.comZimVie Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 28, 2024 | finance.yahoo.comZimVie Inc (ZIMV) Navigates Market Challenges with Strategic Focus on Dental SegmentFebruary 27, 2024 | markets.businessinsider.comWhat Wall Street expects from ZimVie's earningsFebruary 23, 2024 | marketbeat.comAcadian Asset Management LLC Buys 57,159 Shares of ZimVie Inc. (NASDAQ:ZIMV)Acadian Asset Management LLC boosted its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 8.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 730,436 shares of the company's stock after purchasing an adFebruary 22, 2024 | msn.comJapan dental implants to reach $230m in 2033February 21, 2024 | finance.yahoo.comZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024February 21, 2024 | globenewswire.comZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024February 18, 2024 | finance.yahoo.comZIMV Mar 2024 15.000 putFebruary 18, 2024 | finance.yahoo.comZIMV Apr 2024 10.000 call Get ZimVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter. Email Address A letter is coming from the "Bureau of the Fiscal Service". (Ad)Is your bank next? A powerful new trend is spreading like wildfire inside the US financial system. At least 41 banks are already involved. But the Federal Reserve predicts that number will grow fast. See if your bank is involved right here. ZIMV Media Mentions By Week ZIMV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZIMV News Sentiment▼0.860.42▲Average Medical News Sentiment ZIMV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZIMV Articles This Week▼82▲ZIMV Articles Average Week Get ZimVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Theravance Biopharma News Today Fulcrum Therapeutics News Today PepGen News Today Enhabit News Today Corbus Pharmaceuticals News Today Voyager Therapeutics News Today Lexeo Therapeutics News Today Biomea Fusion News Today biote News Today Editas Medicine News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZIMV) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss Ratings41 banks launch ‘crypto dollar’Stansberry ResearchHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZimVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
